7th Meet the Professor. Modena International Breast Cancer Conference (MIBCC) October 5-7, 2011, Modena, Italy
Modena InternatIonal Breast CanCer ConferenCe 〜 7th Meet the professor Modena, 5-6-7 October 2011 University of Modena and Reggio EmiliaSection of Oncology
AiMsThe breast cancer meeting in Modena started seven years ago as a Meet the Professor initiative to facilitate the discussion among recog-nized Experts and physicians involved in breast cancer management. Over the years, the number and the expertise of the attendees hasincreased as has the scientific content of the meeting. This seventh edition is now an international conference that will gather some ofthe top scientists and clinicians from all over the word. The Programme of the Conference includes lectures, round tables on topics thatrequire a multifaceted approach, highlights from international meetings, debates on controversial items and clinical case discussions.Even though the Conference has increased the number of the participants and the international inspiration, this 7th Modena InternationalBreast Cancer Conference will maintain its characteristics of a friendly forum where internationally recognized experts and attendeescan exchange experiences and comment on the most exiting advances in breast cancer biology and therapy. In order to reward scientificexcellence and facilitate international cooperation, the International Scientific Committee of MIBCC 7th, will award the Second Interna-tional Unimore Prize for Breast Cancer Research to a young scientist who has published a breakthrough paper in the previous year andthe Monica Boscolo Research Grant to an Italian scientist willing to pursue a research project in a foreign institution.Medical oncologists, breast surgeons, radiologists, pathologists and basic scientists interested in translational research are welcome toModena to listen to breast cancer leaders and exchange experience in a friendly atmosphere. PierFranco Conte, Gabriel N. HortobagyiAddressed tOOncologists, radiologists, breast surgeonseCMBased on the in force Italian regulations, Accademia Nazionale di Medicina (provider n. 31, accreditation valid through July 13th, 2012) will propose3,5 ECM points.The Meeting is addressed to physicians specialized in oncology, radiology, breast surgeryThe credit certification is subject to:- attendance of at least 80% of the meeting- the completion of the meeting evaluation form- a signed declaration of attendance of the meetingWe would like to remind to participants that only 1/3 of the MCE Credits acquired during the years 2011-2013 can come from a sponsorshipesMO-MOrA CreditsThe course has been accredited with 15 ESMO Mora points.
OffiCiAl lAnguAgeThe official language of the Meeting is English. No simultaneous translation will be provided.registrAtiOnThe registration fee is € 250,00 tax free.It includes the conference bag, the conference book and all coffee breaks and lunches. It does not include hotel accomodation,dinners and travel expenses.To register, please send:• registration form duly filled out (even when sponsored by a Pharmaceutical Company)• privacy statement and consent to the use of personal data (as in the back of the form)• paymentto Accademia Nazionale di Medicina – Palazzina CUP II Piano, Via Massarenti 9, 40138 Bologna – fax 0039 051 6364605 –e-mail: firstname.lastname@example.org, within september 29th.Online registration is possible on the website http://meettheprofessor.accmed.orgBy submitting the form and the payment, your registration is completed with the exception of specific decisionsof the Meeting Secretariat.Incomplete registration will NOT be admitted.CANCEllATION• If the participants minimum number is not reached, Accademia Nazionale di Medicina will advise by a written communication and proceed with the total refund of the fee.• In order to cancel please give advise with a written communication to Accademia Nazionale di Medicina within October 25th. A 70% of the registration fee will be returned. Any cancellation after that deadline will not be reimbursed.
PrOgrAMMeWEdNESdAy, OCTOBER 5th Chairman: Pietro Torricelli 14.15 Round Table 2. Innovation in Reconstructive Surgery Chairman: Giorgio de Santis 9.30 Lecture 1 - Reconstruction with perforator flaps Screening programmes: evidence, limits, perspectives Aldona J. Spiegel Carlo Naldoni - Autologous fat transplantation and external vacuum- assisted therapy 10.00 Lecture 2 Roger Kouri Management of high-risk women: BRCA and beyond - Oncoplastic surgery laura Cortesi Remy Salmon - Reconstructive surgery and radiation therapy 10.30 Coffee break Giorgio de Santis 11.00 Round Table 1. Breast Cancer Prevention 15.40 discussion and coffee break Chairman: Alberto Costa - lifestyle - Massimo Federico 16.10 Clinical Case Discussion 1. Surgical Challenges - Chemoprevention - Andrea de Censi Chairman: Emiel J. Rutgers - Surgery - Emiel J. Rutgers Presenters: Alberto Bottini, Maria Grazia lazzaretti, Emanuela Roncella, Giovanni Tazzioli Chairmen: Filippo Bertoni, Giovanni Tazzioli Panelists: Alberto Costa, Kelly Hunt, Philip Poortmans, Remy Salmon 12.15 H ighlights on Surgery Clinical cases of breast cancers with difficult/ Sentinel node biopsy and axillary node dissection: what controversial characteristics will be presented. is new The audience will vote a list of options and the panelists Kelly Hunt will discuss the votes and express their opinion. 12.45 Highlights on Partial Breast Irradiation 17.40 Adjourn New techniques, new data, ASTRO consensus statement Philip Poortmans 13.15 lunch break
THURSdAy, OCTOBER 6th Chairmen: Pier Franco Conte, Gabriel N. Hortobagyi Sotiriou, Giuseppe Viale, Christoph Zielinski 8.30 Highlights on Molecular Pathology On the basis of the clinical cases presented and the Gene Expression Profiles as prognosticators and audience choices, the discussant will ask the panelists predictors of treatment efficacy to discuss the role of genomic classifiers and molecular Christos Sotiriou markers in treatment decision. 9.00 Round Table 3. Which information pathology reports 12.30 L ecture 3 should provide? Breast cancer stem cells luca Gianni, Giuseppe Viale Maria Grazia daidone - Focal HER2 amplification - Rare histologies 13.00 lunch break - discrepancy between primary and metastases Chairmen: Pier Franco Conte, Gabriel N. Hortobagyi10.00 Clinical Case Discussion 2. Clinicians-Pathologists crosstalk (Part 1) 14.00 Lecture 4 Chairman: Gabriel N. Hortobagyi Adjuvant treatment of EBC 2011 Presenters: Alessandra Gennari, Anna Maria Molino, Gabriel N. Hortobagyi Fabio Puglisi Cases of early breast cancers with clinical or 14.30 Highlights on Bisphosphonates as adjuvant treatment pathological controversial characteristics will be for early breast cancer presented. The audience will vote a list of options. Robert Coleman11.00 Coffee break 15.00 Debate 1. Closing credits for chemotherapy in HR+ EBC? Pro chemotherapy - Miguel Martin11.30 Clinical Case Discussion 2. Clinicians-Pathologists Contra chemotherapy – Christoph Zielinski crosstalk (Part 2) Chairman: Gabriel N. Hortobagyi 16.00 Coffee break Discussant: Valentina Guarneri Panelists: Pier Franco Conte, luca Gianni, Sibylle loibl, 16.20 Highlights on Primary Systemic Therapy for OBC Antonio Maiorana, Miguel Martin, Anna Sapino, Christos Sibylle loibl
16.50 Ceremony for the presentation of the UniMore Award Panelists: Filippo Bertoni, Pier Franco Conte, Marjorie for advances in breast cancer research, the Monica C. Green, Gabriel N. Hortobagyi, Fikri Icli, Stephen Boscolo Research Grant and Patrizia Rossi merit Johnston award. Cases of advanced breast cancers with limited tumor burden or metastatic sites eligible for a multidisciplinary 17.10 Lecture of the Unimore awardee treatment will be presented and the panelists will discuss the audience choices and express their opinion. 17.40 Adjourn 12.30 Highlights on advanced HR+ disease Paolo PronzatoFRIdAy, OCTOBER 7th 12.50 Highlights on Metastatic Bone Disease Chairmen: Pier Franco Conte, Steven Johnston Antonio Frassoldati 8.30 Lecture 5 13.10 Update on ongoing adjuvant trials in HER2+ EBC Inflammatory breast cancer Valentina Guarneri Hussein Khaled 13.30 Adjourn and final evaluation questionnaire 9.00 D ebate 2. Closing credits for chemotherapy in HER2+ disease? Pro chemotherapy – david Khayat Contra chemotherapy – Steven Johnston 10.00 Coffee break 10.30 L ecture 6 Triple negative breast cancer: how many diseases, how many therapies? Marjorie C. Green 11.00 Clinical Case Discussion 3. Multidisciplinary approach to metastatic breast cancer Chairman: Jacek Jassem Presenters: Carmelo Bengala, Roberto Sabbatini, Claudio Zamagni
direCtOrsPier Franco Conte David Khayatdepartment of Oncology, Hematology and Respiratory diseases Medical Oncology departmentdivision of Oncology Salpetriere HospitalUniversity of Modena and Reggio Emilia (I) Paris, FranceGabriel N. Hortobagyi Sibylle Loibldepartment of Breast Medical Oncology German Breast GroupUniversity of Texas - Md Anderson Cancer Center UniversityHouston (USA) Frankfurt (d) Miguel Martin Medical Oncology ServicesCientifiC COMMittee Hospital Universitario Gregorio Maranon Madrid (E)Fikri IçliOncology Research and Treatment Center Christoph ZielinskiAnkara University (TR) Clinical division of Oncology Medical University - General HospitalJacek Jassem Vienna (A)department of Oncology and RadiotherapyMedical University of Gdansk (Pl)Stephen JohnstonNIHR Biomedical Research Centre for CancerRoyal Marsden NHS Foundation Trust & Instituteof Cancer Researchlondon (UK)Hussein KhaledMedical Oncology departmentNational Cancer InstituteCairo University (ET)
lOCAl sCientifiC And sPeAkersOrgAnizing COMMittee Carmelo Bengala department of Oncology, Hematology and Respiratory diseasesGiorgio De Santis division of Oncologydepartment of head-neck surgery University of Modena and Reggio Emilia (I)University Hospital of ModenaUniversity of Modena and Reggio Emilia (I) Filippo Bertoni department of RadiotherapyAntonio Frassoldati University of Modena and Reggio Emilia (I)department of OncologyUniversity Hospital of Ferrara (I) Alberto Bottini Breast UnitValentina Guarneri A.O. Istituti Ospedalieri di Cremona (I)department of Oncology, Hematology and Respiratory diseasesdivision of Oncology Robert ColemanUniversity of Modena and Reggio Emilia (I) Weston Park Hospital / University of Sheffield Sheffield (UK)Antonino Maioranadepartment of laboratories Laura CortesiPathology and Forensic Medicine department of Oncology, Hematology and Respiratory diseasesUniversity Hospital of Modena division of OncologyUniversity of Modena and Reggio Emilia (I) University of Modena and Reggio Emilia (I)Giovanni Tazzioli Alberto Costadepartment of General Surgery and Surgical Specialities European School of OncologyUniversity Hospital of Modena Milan (I)University of Modena and Reggio Emilia (I) Maria Grazia DaidonePietro Torricelli department of Experimental Oncology and Molecular Medicinedepartment of diagnostic services and imaging National Cancer InstituteUniversity Hospital of Modena Milan (I)University of Modena and Reggio Emilia (I)
Andrea De Censi Marjorie C. Greendivision of Medical Oncology department of Breast Medical OncologyEO Ospedali Galliera division of Cancer MedicineGenoa (I) University of Texas - Md Anderson Cancer Center Houston (USA)Giorgio De Santisdepartment of head-neck surgery Valentina GuarneriUniversity Hospital of Modena department of Oncology, Hematology and Respiratory diseasesUniversity of Modena and Reggio Emilia (I) division of Oncology University of Modena and Reggio Emilia (I)Massimo Federicodepartment of Oncology, Hematology and Respiratory diseases Kelly Huntdivision of Oncology department of Surgical OncologyUniversity of Modena and Reggio Emilia (I) University of Texas Md Anderson Cancer CenterAntonio Frassoldati Houston, Texas (USA)department of OncologyUniversity Hospital of Ferrara (I) Fikri Içli Oncology Research and Treatment CenterAlessandra Gennari Ankara University (TR)division of Medical OncologyEO Ospedali Galliera Jacek JassemGenoa (I) department of Oncology and Radiotherapy Medical University of Gdansk (Pl)Luca Giannidepartment of Medical Oncology 1Q-A Stephen JohnstonS. Raffaele Institute NIHR Biomedical Research Centre for CancerMilan (I) Royal Marsden NHS Foundation Trust & Institute of Cancer Research london (UK)
Hussein Khaled Miguel MartinMedical Oncology department Medical Oncology ServiceNational Cancer Institute Hospital Universitario Gregorio MaranonCairo University (ET) Madrid (E)David Khayat Anna Maria MolinoMedical Oncology department Breast UnitSalpetriere Hospital University HospitalParis, France Verona (I)Roger K.Khouri Carlo NaldoniMiami Breast Center Emilia-RomagnaBreast Surgery & Reconstruction local Governement Health PoliciesKey Biscayne, Fl (USA) Bologna (I)Maria Grazia Lazzaretti Philip PoortmansBreast Unit department of Radiation OncologyRamazzini Hospital dr. Verbeeten InstituutCarpi, Modena (I) Tilburg (Nl)Sibylle Loibl Paolo PronzatoGerman Breast Group department of Medical OncologyUniversity National Cancer InstituteFrankfurt (d) Genoa (I)Antonino Maiorana Fabio Puglisidepartment of laboratories, department of OncologyPathology and Forensic Medicine University Hospital of Udine (I)University Hospital of ModenaUniversity of Modena and Reggio Emilia (I) Manuela Roncella Breast Unit University Hospital S. Chiara Pisa (I)
Emiel Rutgers Giovanni TazzioliThe Netherlands Cancer Institute department of General Surgery and Surgical SpecialitiesAntoni van leeuwenhoek Hospital University Hospital of ModenaAmsterdam (Nl) University of Modena and Reggio Emilia (I)Roberto Sabbatini Pietro Torricellidepartment of Oncology, Hematology and Respiratory diseases department of diagnostic services and imagingdivision of Oncology University Hospital of ModenaUniversity of Modena and Reggio Emilia (I) University of Modena and Reggio Emilia (I)Remy Salmon Giuseppe Vialedepartment of Surgery department of PathologyInstitut Curie European Institute of OncologyParis (F) University of Milan (I)Anna Sapino Claudio Zamagnidepartment of Biomedical Sciences and Human Oncology Medical Oncology UnitUniversity of Turin Policlinico S.Orsola-Malpighi HospitalTurin (I) Bologna (I)Christos Sotiriou Christoph ZielinskiUnitè de Oncologie Clinical division of OncologyIstitut Jules Bordet Medical University - General HospitalBrussels (B) Vienna (A)Aldona J.SpiegelThe Center for Breast RestorationThe Methodist HospitalHouston, Texas (USA)
with the PAtrOnAge Of: University of Modena and Reggio Emilia Associazione Italiana di Radioterapia Oncologica Associazione Italiana di Oncologia Medica senology.org
with the unCOnditiOnAl COntributiOn OfGoLD SPoNSoRSILVER SPoNSoR
Meeting Venue sPOnsOred by Scholarship Fondazione Federico CalabresiAula Magna Centro Didattico ACCADEMIA NAZIoNALE DI MEDICINA The Scholarship includes a reward ofPoliclinico di Modena € 1000,00, the registration fee, travel and accom- modation in Modena for the Meeting. It will beVia del Pozzo, 71 assigned to the best publication on InternationalModena www.accmed.org press during the current year or "in press" to the General Manager: Stefania ledda date July 20th, 2011. The main author must behOw tO reACh the Meeting Venue a clinical oncologist younger than 45 years old. In a joint collaboration with: Please send the request together with two copiesBy car arriving from the North: Integrated department of Oncology of the work within July 15th to Accademia Nazio- nale di Medicina, Via Martin Piaggio 17/6, 16122exit Modena North, follow the signs to and Haematology Genova – Subject: MIBCCCity Center-Bologna Strada Statale, University of Modena and Reggio Emiliathen follow directions to the Hospital Monica Boscolo Research GrantPoliclinico of Modena. The Scientific Committee will select the win- ner of the Monica Boscolo Research Grant.By car arriving from the South: exit OrgAnizing PArtner This Research Award is restricted to young Italian researchers (<40 years) who will carryModena South, turn right then keep out a research project at a foreign institu-going for 10 Km, at the mandatory turn Forum Service tion. The award is made for an amount up tosign, turn right and follow the street to Via Martin Piaggio 17/6 € 24.000.the end. 16122 Genova Unimore Award The Scientific Committee will select young re-By train: Modena train station, bus n. 7. Information: searchers (<40 years from any country) who http://meettheprofessor.accmed.org have published in an international peer-reviewedBy plane: Bologna Aeroport 40 Km. Ph. 0039 051 6364898-6360080 journal, as the principal author, a manuscript re- Fax 0039 051 6364605 porting important clinical or biological advances email@example.com in breast cancer. Prof. Conte and Prof. Hortobagyi will select the final winner which will be invited to present his/her study during the annual Con- Hotel booking: ference. The Unimore Award consists of € 6.000. Ph. 0039 010 83794235 Fax 0039 010 83794261 Patrizia Rossi Merit Award firstname.lastname@example.org This award is rescricted to students of the University of Modena and Reggio Emilia who have graduated in 2010/2011 with a graduation thesis on biological or clinical aspects of breast cancer. The award consists of € 1.000.